Tutt, Andrew http://orcid.org/0000-0001-8715-2901
Tovey, Holly
Cheang, Maggie Chon U.
Kernaghan, Sarah
Kilburn, Lucy
Gazinska, Patrycja
Owen, Julie
Abraham, Jacinta
Barrett, Sophie
Barrett-Lee, Peter
Brown, Robert
Chan, Stephen
Dowsett, Mitchell
Flanagan, James M
Fox, Lisa
Grigoriadis, Anita http://orcid.org/0000-0003-3434-201X
Gutin, Alexander
Harper-Wynne, Catherine
Hatton, Matthew Q.
Hoadley, Katherine A.
Parikh, Jyoti
Parker, Peter
Perou, Charles M.
Roylance, Rebecca
Shah, Vandna
Shaw, Adam
Smith, Ian E.
Timms, Kirsten M.
Wardley, Andrew M. http://orcid.org/0000-0002-9639-0888
Wilson, Gregory
Gillett, Cheryl
Lanchbury, Jerry S.
Ashworth, Alan
Rahman, Nazneen
Harries, Mark
Ellis, Paul
Pinder, Sarah E. http://orcid.org/0000-0003-4167-8910
Bliss, Judith M.
Article History
Received: 24 November 2017
Accepted: 2 March 2018
First Online: 30 April 2018
Competing interests
: A.T., H.T., M.C.U.C., S.K., L.K., P.G., J.O., R.B., M.D., L.F., A.G., P.P., V.S., C.G., N.R., S.E.P. and J.M.B. report that their institutional departments have received grants from Breast Cancer Now and/or Cancer Research UK and other support for costs or consumables in this research from Myriad Genetics, Inc. and NanoString Technologies, Inc. during the conduct of the study. M.C.U.C. has a patent: US Patent No. 9,631,239 with royalties paid. M.D. reports receiving personal fees from Myriad Genetics, Inc. outside of the submitted work. A.Gu. reports receiving salary compensation and stock/options from Myriad Genetics, Inc. during conduct of the study and has patent rights assigned to Myriad Genetics. C.M.P. reports receiving personal fees from Bioclassifier LLC, consulting fees from Nanostring Technologies outside the submitted work. In addition, C.M.P. has a patent: U.S. Patent No. 9,631,239 with royalties paid. K.M.T. reports receiving personal fees from Myriad Genetics, Inc. during the conduct of the study and personal fees from Myriad Genetics, Inc. outside the submitted work. In addition, K.T. has the following patents pending: 13/164,499; 14/554,715; 15/010,721; 15/192,497; 14/245,576; 62/000,000; 62/311,231; 62/332,526; 14/962,588; 2802882; 11796544.2; 15189527.3; 2,839,210; 12801070.9; 2014-516031; 2012358244; 2,860,312; 201280070358.0; 12860530.0; 2014-548965; 2014248007; 2,908,745; 14779403.6; 2016-506657; 712,663; PCT/US15/045561; PCT/US15/064473; and the following patents issued to Myriad Genetics, Inc.: 9,279,156; 9,388,427 and 625468. J.S.L. reports salary compensation and stock/options from Myriad Genetics Inc. received during conduct of the study. The other authors declare no competing interests.